Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zewei Wang

Showing results (121-130 of 158) with videos related to

Pageof 16
Sort By:
ACS Applied Materials & Interfaces|March 16, 2026
Air Discharge Plasma-Activated Hydrosols with Phased RONS-Mediated Anti-Infection, Anti-Inflammation, and Tissue Remodeling Effects for the Integrated Treatment of Chronic WoundsHao Zhang, Xixi Jing, Zewei Wang, et al.
ACS Applied Bio Materials|January 13, 2022
Facile and Modular Pipeline for Protein-Specific Antibody CustomizationShubing Tang, Tian Han, Zewei Wang, et al.
Cancer Immunology, Immunotherapy : CII|October 30, 2021
Infiltration and Polarization of Tumor-associated Macrophages Predict Prognosis and Therapeutic Benefit in Muscle-Invasive Bladder CancerMengmeng Sun, Han Zeng, Kaifeng Jin, et al.
Journal for Immunotherapy of Cancer|January 6, 2025
Lethal clinical outcome and chemotherapy and immunotherapy resistance in patients with urothelial carcinoma with MDM2 amplification or overexpressionKaifeng Jin, Yawei Ding, Jingtong Xu, et al.
Cancer|June 29, 2026
Proliferative ecotype determines lethal prognosis and therapeutic benefit in urothelial carcinomaJiaxing Sun, Kaifeng Jin, Yawei Ding, et al.
Journal for Immunotherapy of Cancer|May 20, 2026
Aberrant p53 fuels macrophage immunoregulatory polarization and refractory clinical outcome in urothelial carcinomaYawei Ding, Kaifeng Jin, Xiaohe Su, et al.
Cancer Immunology, Immunotherapy : CII|June 21, 2021
Latency-associated peptide identifies therapeutically resistant muscle-invasive bladder cancer with poor prognosisRuiting Ye, Han Zeng, Zhaopei Liu, et al.
British Journal of Cancer|May 15, 2026
Lethal clinical outcome and immuno-fibrotic contexture in refractory urothelial carcinoma harboring MYC amplification and overexpressionLingkai Zhang, Zhaopei Liu, Yawei Ding, et al.
Annali Italiani Di Chirurgia|April 15, 2025
Advanced Diagnosis and Treatment Methods of High-Pressure Injection Injury: A Single-Center Retrospective Case Series StudyWeijie Zhou, Ahmad Alhaskawi, Haiying Zhou, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|April 30, 2026
Severe acute limb ischemia in patients with COVID-19: a single-center case seriesChengjun Yao, Yanzhao Dong, Xiaodi Zou, et al.
Pageof 16

Showing results (121-130 of 158) with videos related to

Sort By:
Pageof 16
ACS Applied Materials & Interfaces|March 16, 2026
Air Discharge Plasma-Activated Hydrosols with Phased RONS-Mediated Anti-Infection, Anti-Inflammation, and Tissue Remodeling Effects for the Integrated Treatment of Chronic WoundsHao Zhang, Xixi Jing, Zewei Wang, et al.
ACS Applied Bio Materials|January 13, 2022
Facile and Modular Pipeline for Protein-Specific Antibody CustomizationShubing Tang, Tian Han, Zewei Wang, et al.
Cancer Immunology, Immunotherapy : CII|October 30, 2021
Infiltration and Polarization of Tumor-associated Macrophages Predict Prognosis and Therapeutic Benefit in Muscle-Invasive Bladder CancerMengmeng Sun, Han Zeng, Kaifeng Jin, et al.
Journal for Immunotherapy of Cancer|January 6, 2025
Lethal clinical outcome and chemotherapy and immunotherapy resistance in patients with urothelial carcinoma with MDM2 amplification or overexpressionKaifeng Jin, Yawei Ding, Jingtong Xu, et al.
Cancer|June 29, 2026
Proliferative ecotype determines lethal prognosis and therapeutic benefit in urothelial carcinomaJiaxing Sun, Kaifeng Jin, Yawei Ding, et al.
Journal for Immunotherapy of Cancer|May 20, 2026
Aberrant p53 fuels macrophage immunoregulatory polarization and refractory clinical outcome in urothelial carcinomaYawei Ding, Kaifeng Jin, Xiaohe Su, et al.
Cancer Immunology, Immunotherapy : CII|June 21, 2021
Latency-associated peptide identifies therapeutically resistant muscle-invasive bladder cancer with poor prognosisRuiting Ye, Han Zeng, Zhaopei Liu, et al.
British Journal of Cancer|May 15, 2026
Lethal clinical outcome and immuno-fibrotic contexture in refractory urothelial carcinoma harboring MYC amplification and overexpressionLingkai Zhang, Zhaopei Liu, Yawei Ding, et al.
Annali Italiani Di Chirurgia|April 15, 2025
Advanced Diagnosis and Treatment Methods of High-Pressure Injection Injury: A Single-Center Retrospective Case Series StudyWeijie Zhou, Ahmad Alhaskawi, Haiying Zhou, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|April 30, 2026
Severe acute limb ischemia in patients with COVID-19: a single-center case seriesChengjun Yao, Yanzhao Dong, Xiaodi Zou, et al.
Pageof 16